Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010075521) COMPOSITIONS AND METHODS OF TREATING CANCER
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/075521 International Application No.: PCT/US2009/069425
Publication Date: 01.07.2010 International Filing Date: 23.12.2009
IPC:
A61K 38/00 (2006.01) ,A61K 31/7088 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7088
Compounds having three or more nucleosides or nucleotides
Applicants:
CASE WESTERN RESERVE UNIVERSITY [US/US]; 10900 Euclid Avenue Cleveland, OH 44106, US (AllExceptUS)
SY, Man-Sun [US/US]; US (UsOnly)
XIN, Wei [US/US]; US (UsOnly)
LI, Chaoyang [CN/US]; US (UsOnly)
YU, Shuiliang [CN/US]; US (UsOnly)
YIN, Shaoman [CN/US]; US (UsOnly)
Inventors:
SY, Man-Sun; US
XIN, Wei; US
LI, Chaoyang; US
YU, Shuiliang; US
YIN, Shaoman; US
Agent:
SUTKUS, Richard, A.; Tarolli, Sundheim, Covell & Tummino LLP 1300 East Ninth Street Suite 1700 Cleveland, OH 44114, US
Priority Data:
61/140,13023.12.2008US
Title (EN) COMPOSITIONS AND METHODS OF TREATING CANCER
(FR) COMPOSITIONS ET MÉTHODES DE TRAITEMENT DU CANCER
Abstract:
(EN) A method of inhibiting neoplastic, cancer, and/or tumorgenic cell proliferation, cell growth and motility in a subject includes administering to a cancer cell expressing Pro-PrP and FLNa a therapeutically effective amount of a Pro-PrP regulating agent.
(FR) Une méthode d'inhibition de la prolifération des néoplasmes, du cancer et/ou des cellules génératrices de tumeurs, de la croissance et de la motilité cellulaires inclut l'administration dans une cellule cancéreuse exprimant Pro-PrP et FLNa d'une quantité thérapeutiquement active d'un agent régulateur Pro-PrP.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
US20110257102